Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of the National Cancer Institute (JNCI)
Daily low-dose endoxifen reduced mammographic breast density versus placebo in premenopausal women, with fewer tolerability concerns at 1 mg. Whether this surrogate response translates into lower breast cancer incidence remains unknown.
Medical Oncology August 31st 2026
Medical News Today (MNT)
The American College of Physicians issued updated breast cancer screening guidance recommending biennial mammography for average-risk women aged 50 to 74, with shared decision-making for those 40 to 49 and discontinuation discussions after 74.
Family Medicine/General Practice May 6th 2026
Annals of Internal Medicine
ACP updated guidance recommends shared decision-making rather than routine biennial mammography for average-risk women aged 40 to 49, diverging from the USPSTF recommendation.
Family Medicine/General Practice April 28th 2026
MDSpire News
Breast cancer screening remains a persistent area of variation in clinical practice. Updated guidance from the American College of Physicians aims to clarify when screening offers meaningful benefit for average‑risk patients — and when it may not.
Internal Medicine April 22nd 2026